• 1
    Chinn S, Jarvis D, Burney P, et al. Increase in diagnosed asthma but not in symptoms in the European Community Respiratory Health survey. Thorax. 2004;59: 64651.
  • 2
    Asher MI, Montefort S, Bjorksten B, Lai CK, Strachan DP, Weiland SK, Williams H. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368: 73343.
  • 3
    Beasley R. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351: 122532.
  • 4
    Janson C, Anto J, Burney P, et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J. 2001;18: 598611.
  • 5
    Buist AS, McBurnie MA, Vollmer WM, et al. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 2007;370: 74150.
  • 6
    Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368: 80413.
  • 7
    Anonymous. A plea to abandon asthma as a disease concept. Lancet. 2006;368: 705.
  • 8
    Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121: 143440.
  • 9
    Gudmundsson G, Gislason T, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P, Janson C. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res. 2006;7: 109.
  • 10
    Rönmark E, Jonsson E, Platts-Mills T, Lundbäck B. Different pattern of risk factors for atopic and nonatopic asthma among children – report from the Obstructive Lung Disease in Northern Sweden Study. Allergy. 1999;54: 92635.
  • 11
    Janson C, Kalm-Stephens P, Foucard T, Alving K, Nordvall SL. Risk factors associated with allergic and non-allergic asthma in adolescents. Clin Respir J. 2007;1: 1622.
  • 12
    Sunyer J, Anto JM, Kogevinas M, Soriano JB, Tobias A, Munoz A. Smoking and bronchial responsiveness in nonatopic and atopic young adults. Spanish Group of the European Study of Asthma. Thorax. 1997;52: 2358.
  • 13
    Plaschke PP, Janson C, Norrman E, Björnsson E, Ellbjar S, Jarvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med. 2000;162: 9204.
  • 14
    Nieves A, Magnan A, Boniface S, Proudhon H, Lanteaume A, Romanet S, Vervloet D, Godard P. Phenotypes of asthma revisited upon the presence of atopy. Respir Med. 2005;99: 34754.
  • 15
    Amin K, Ludviksdottir D, Janson C, Nettelbladt O, Björnsson E, Roomans GM, Boman G, Seveus L, Venge P. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med. 2000;162: 2295301.
  • 16
    Humbert M, Menz G, Ying S, Corrigan CJ, Robinson DS, Durham SR, Kay AB. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today. 1999;20: 52833.
  • 17
    Karjalainen EM, Lindqvist A, Laitinen LA, Kava T, Altraja A, Halme M, Laitinen A. Airway inflammation and basement membrane tenascin in newly diagnosed atopic and nonatopic asthma. Respir Med. 2003;97: 104551.
  • 18
    de Marco R, Marcon A, Jarvis D, et al. Inhaled steroids are associated with reduced lung function decline in subjects with asthma with elevated total IgE. J Allergy Clin Immunol. 2007;119: 61117.
  • 19
    Björnsson E, Janson C, Håkansson L, Enander I, Venge P, Boman G. Serum eosinophil cationic protein in relation to bronchial asthma in a young Swedish population. Allergy. 1994;49: 7306.
  • 20
    Björnsson E, Janson C, Håkansson L, Enander I, Venge P, Boman G. Eosinophil peroxidase: a new serum marker of atopy and bronchial hyper-responsiveness. Respir Med. 1996;90: 3946.
  • 21
    Olafsdottir IS, Gislason T, Thjodleifsson B, Olafsson I, Gislason D, Jõgi R, Janson C. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study. Thorax. 2005;60: 4514.
  • 22
    Ludviksdottir D, Janson C, Högman M, Hedenström H, Björnsson E, Boman G. Exhaled nitric oxide and its relationship to airway responsiveness and atopy in asthma. BHR-Study Group. Respir Med. 1999;93: 5526.
  • 23
    Ludviksdottir D, Janson C, Björnsson E, Stålenheim G, Boman G, Hedenström H, Venge P, Gudbjörnsson B, Valtysdottir S. Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjögren's syndrome. BHR Study Group. Bronchial hyperresponsiveness. Allergy. 2000;55: 25965.
  • 24
    Amin K, Janson C, Boman G, Venge P. The extracellular deposition of mast cell products is increased in hypertrophic airways smooth muscles in allergic asthma but not in nonallergic asthma. Allergy. 2005;60: 12417.
  • 25
    The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. European Network for Understanding Mechanisms of Severe Asthma. Eur Respir J. 2003;22: 4707.
  • 26
    Cazzoletti L, Marcon A, Janson C, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol. 2007;120: 13607.
  • 27
    de Marco R, Marcon A, Jarvis D, et al. Prognostic factors of asthma severity: a 9-year international prospective cohort study. J Allergy Clin Immunol. 2006;117: 124956.
  • 28
    Celli BR, Cote CG, Marin JM, Casanova C, Montes DO, Mendez RA, Pinto PV, Cabral HJ. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350: 100512.
  • 29
    Scadding JG. Meaning of diagnostic terms in broncho-pulmonary disease. Br Med J. 1963;2: 142530.
  • 30
    Hallin R, Gudmundsson G, Suppli UC, Nieminen MM, Gislason T, Lindberg E, Brøndum E, Aine T, Bakke P, Janson C. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2007;101: 195460.
  • 31
    Dahlén I, Janson C. Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease. Chest. 2002;122: 16337.
  • 32
    Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, Brøndum E, Nieminen MM, Aine T, Bakke P. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26: 41419.
  • 33
    Emtner MI, Arnardottir HR, Hallin R, Lindberg E, Janson C. Walking distance is a predictor of exacerbations in patients with chronic obstructive pulmonary disease. Respir Med. 2007;101: 103740.